Today: 30 April 2026
Chevron (CVX) Stock: What to Know Before the U.S. Market Opens on Dec. 26, 2025 — Oil Prices, Venezuela Risk, New Catalysts, and Analyst Targets
26 December 2025
6 mins read

Chevron (CVX) Stock: What to Know Before the U.S. Market Opens on Dec. 26, 2025 — Oil Prices, Venezuela Risk, New Catalysts, and Analyst Targets

Chevron Corporation (NYSE: CVX) heads into the Friday, Dec. 26, 2025 U.S. session as investors return from the Christmas Day market closure with oil prices, geopolitical supply risks, and a steady drumbeat of portfolio headlines back in focus.

Chevron last traded on Wednesday, Dec. 24, ending at $150.50.

Below is a premarket-style briefing on the most important drivers, fresh company news, Street forecasts, and near-term catalysts that could shape CVX trading into year-end.


Chevron stock snapshot heading into Dec. 26

  • Last price (Dec. 24): $150.50
  • Day range (Dec. 24): $150.10 – $150.99
  • 52-week range: roughly $132–$169 (CVX currently sits near the middle of its yearly band)

That “middle-of-the-range” positioning is important: it suggests CVX may be trading less on technical extremes and more on macro inputs (crude prices), headline risk (Venezuela/Russia), and company execution (capital discipline + Hess integration) into early 2026.


1) The big driver for CVX before the bell: crude oil’s holiday bounce vs. the 2026 oversupply narrative

Energy stocks can move on many things, but crude direction is still the fastest lever for Chevron on a day-to-day basis—especially during thin year-end liquidity.

Where oil prices stand

On Dec. 24, Reuters reported:

  • Brent settled around $62.24/bbl
  • WTI settled around $58.29/bbl

Reuters also flagged that crude had rebounded about 6% since Dec. 16 (after sliding to near five-year lows), but was still on track for a steep full-year decline (roughly -16% Brent and -18% WTI for 2025).

Why this matters for Chevron

Chevron’s cash flows and investor-return capacity are highly sensitive to the crude tape—but the company has also been trying to make the narrative less “oil-price-only” by emphasizing capital discipline, cost takeout, and advantaged barrels. Those themes have been reinforced repeatedly in late-2025 strategy messaging. Reuters


2) Geopolitics are directly in Chevron’s lane right now: Venezuela and Kazakhstan export disruption

A) Venezuela: blockade headlines + Chevron’s unique position

Venezuela is back as a market-moving storyline after reports of U.S. actions disrupting Venezuelan tanker movements. Reuters reported that loading slowed, ships altered routes, and PDVSA faced operational strain (including recovery efforts after a cyberattack), while oil prices reacted to perceived supply risk.

The Chevron-specific angle: Reuters noted that Chevron continued shipments to the U.S. under special authorization, including multiple cargoes during the month, even as broader flows were disrupted.

A separate Reuters report added color that PDVSA began using floating storage as onshore tanks filled, with Venezuela’s total inventories nearing ~22 million barrels—the highest since August 2025—while Chevron’s joint ventures were still operating and were described as a meaningful portion of output in the Orinoco region.

What to watch before the open: any incremental Venezuela headline can move crude, which can then move CVX—sometimes more than company-specific news does during holiday trading.


B) Kazakhstan / CPC pipeline: supply risk that involves Chevron directly

Reuters also reported that Kazakhstan’s CPC Blend exports were revised down sharply for December due to delays repairing Russian loading infrastructure after Ukrainian drone strikes, with exports dropping to ~1.14 million bpd versus an initial plan of ~1.7 million bpd. Reuters explicitly noted that the CPC terminal is the export outlet for Kazakhstan oil produced by majors including Chevron.

Why CVX investors should care:

  • It’s another geopolitical supply-risk bid under global crude prices, which can be supportive for integrated majors.
  • It also highlights operational and export-route fragility in a region tied to Chevron’s upstream footprint (and the broader “reliability of barrels” conversation).

3) Fresh Chevron headlines: Singapore refinery stake talks and Eastern Mediterranean gas momentum

A) Singapore: potential portfolio move in downstream

A Reuters report (citing Bloomberg) said Japan’s Eneos was leading bids for Chevron’s 50% stake in a Singapore refinery on Jurong Island (about 290,000 bpd capacity). The refinery value was estimated around $1 billion, with other reported bidders including Vitol and Glencore.

Why this matters:
This fits a broader theme Chevron has emphasized—simplifying, recycling capital, and prioritizing higher-return opportunities. Asset sales and portfolio reshaping also connect to the company’s cost and efficiency push discussed at investor day.


B) Eastern Mediterranean gas: Israel approves major export deal to Egypt

Reuters reported that Israel approved what it described as its largest-ever gas deal: an agreement (signed in August) involving Chevron and partners to supply up to ~$35 billion in gas to Egypt from the Leviathan field, with about 130 bcm through 2040 (or until contract values are met). Chevron welcomed the export permit decision, and the approval ties into expansion planning for Leviathan.

Investor takeaway:
This is not a “day-trading catalyst” like WTI prints—but it strengthens the medium-term case that Chevron has large-scale, long-life gas assets alongside its oil portfolio, and it underlines why Chevron continues to highlight the Eastern Mediterranean in capital plans. Reuters


4) Strategy and guidance: Chevron is selling a “durable cash flow” story into 2026–2030

2026 capex: disciplined spending with a U.S. focus

Reuters reported Chevron’s 2026 capex budget of $18–$19 billion, with about:

  • ~$17B upstream
  • ~$9B allocated to the United States
  • ~$6B aimed at American shale, with Chevron targeting >2 million boepd from the U.S. next year
  • ~$7B offshore (including Guyana, Eastern Mediterranean, U.S. Gulf of Mexico)
  • ~$1B downstream

This framing matters because investors often judge majors on whether they’re “chasing barrels” or chasing returns—and Chevron’s language continues to emphasize return discipline.

Investor day targets: >10% annual free cash flow growth (at $70 Brent)

Reuters also reported that at investor day Chevron targeted:

  • >10% annual free cash flow growth through 2030
  • 2–3% annual production growth
  • $18–$21B annual capex range
  • $3–$4B in cost reductions by end of 2026
  • and it stated it can cover capex + dividend even around $50 Brent

Chevron’s strategic “pitch” going into 2026 is essentially: high confidence in cash generation, lower spending intensity than peers, and the ability to keep returning cash even in weaker oil scenarios. Reuters


5) Hess integration still matters—and it showed up in the numbers

Chevron’s 2025 narrative can’t be told without Hess.

  • Reuters reported that in Q3 2025 the combined Chevron/Hess company produced a record ~4.1 million boepd, and Chevron returned significant cash to shareholders (dividends + buybacks) during the quarter.
  • Reuters also reported Chevron completed the Hess acquisition in July 2025 after arbitration, and it has discussed synergy targets (including a $1B run-rate synergy goal by end of 2025).

Why this remains relevant before Dec. 26:
Even though the deal is closed, the market will keep re-pricing Chevron based on whether it delivers on the execution story: synergy capture, capex discipline, and production/cash-flow delivery from Guyana-linked assets and other Hess additions.


6) Dividend watch: the yield is attractive, but the payout math is worth monitoring

Chevron remains a core holding for many income investors.

StockAnalysis lists:

  • Annual dividend:$6.84/share
  • Dividend yield:~4.54%
  • Last ex-dividend date:Nov. 18, 2025
  • Quarterly dividend:$1.71
  • Dividend growth streak:38 years
  • Payout ratio (as listed):~96%

Interpretation for investors:

  • The yield is still a big part of the “why CVX” case.
  • But when payout ratios look elevated, investors tend to scrutinize the next earnings cycle more closely—especially if crude weakens again.

7) Wall Street forecasts: what analysts are pricing in for CVX

Consensus views vary by data provider, but Investing.com’s consensus snapshot shows:

  • 24 analysts
  • Average target:~$172.33
  • High:~$204
  • Low:~$124
  • Consensus rating leaning “Buy” (with a meaningful hold cohort) Investing

Recent target moves and rating chatter

Recent notes reported by market aggregators show multiple firms lifting targets into late 2025 (for example, Mizuho moving to $206 in mid-December), while other updates included more cautious shifts to “hold.” MarketBeat

How to use this as a premarket input:

  • If CVX is trading around $150, the ~$170+ average target implies moderate upside—but that upside is typically contingent on oil stability + execution (capex discipline, Guyana/Hess integration, cost reductions).

8) Near-term calendar: what could actually move CVX on Dec. 26

Data and event timing to note

  • Reuters noted U.S. official inventory data (EIA) was expected later than usual because of the holiday schedule.
  • Baker Hughes’ rig count schedule also shifts around the holidays; Baker Hughes noted the Christmas-week rig count was published Tuesday, Dec. 23, instead of Friday, Dec. 26.

The practical trading reality

With year-end liquidity, CVX can sometimes react more sharply to:

  • crude futures direction,
  • sudden geopolitical headlines (Venezuela, Russia/Ukraine energy infrastructure),
  • and broad “risk-on/risk-off” market tone—
    than to slower-burning fundamentals.

9) Risks CVX investors should keep front and center

A balanced premarket view requires the bear case, too:

  1. Oil price downside / 2026 surplus fears: even with the recent bounce, the market is still grappling with the idea that supply could outpace demand next year.
  2. Geopolitical headline whiplash: Venezuela enforcement actions and Russia/Ukraine-related energy disruptions can swing crude quickly.
  3. Execution risk: Hess integration + synergy capture are measurable over coming quarters, and the market tends to punish misses.
  4. Cost and restructuring complexity: Chevron has discussed significant cost reduction efforts and workforce changes extending into 2026, which can be disruptive if not managed well.
  5. Downstream volatility: refining margins can swing sharply, and downstream results can be a surprise factor quarter to quarter.

Bottom line for Dec. 26: Chevron enters the session with supportive headlines—but crude still sets the tone

Chevron stock goes into the Dec. 26, 2025 open with multiple supportive elements in the background:

  • crude prices have stabilized off lows,
  • geopolitical supply risks are back in the tape (Venezuela, CPC/Kazakhstan),
  • and Chevron is actively reinforcing a disciplined capital and cash-flow narrative (2026 capex plan + investor day targets).

But in the immediate premarket window, the question is simple: does oil keep its bid—or fade in thin trade? If crude holds up, CVX typically has a clearer runway; if crude rolls over, even strong company messaging can get drowned out.

This article is for informational purposes only and is not investment advice.

Stock Market Today

  • Biogen Shares Rise 6% After Q1 Earnings Beat Despite Guidance Cut
    April 29, 2026, 9:29 PM EDT. Biogen (NASDAQ: BIIB) shares rose 6% on Wednesday following its first-quarter 2026 earnings report. The biotech posted $2.48 billion in revenue, surpassing analyst expectations of $2.25 billion. Net income, excluding accounting standards (GAAP), increased 19% to over $529 million, or $3.57 per share, above forecasts of $2.95. Growth was driven by strong sales of Leqembi, for early Alzheimer's, up 74%, and the FDA-approved Skyclarys for Friedreich's ataxia. However, Biogen cut full-year adjusted net income guidance by $1 per share citing research and development charges. Revenue is expected to decline mid-single digits from 2025, excluding a pending $5.6 billion acquisition of Apellis Pharmaceuticals. Biogen's strategic shift towards high-potential therapies is underway despite cautious outlook.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Procter & Gamble (PG) Stock: CEO Change, January Earnings Date, Tariff Outlook and Analyst Targets to Watch Before the Dec. 26, 2025 Market Open
Previous Story

Procter & Gamble (PG) Stock: CEO Change, January Earnings Date, Tariff Outlook and Analyst Targets to Watch Before the Dec. 26, 2025 Market Open

UnitedHealth Group (UNH) Stock: What to Know Before the U.S. Market Opens on Dec. 26, 2025
Next Story

UnitedHealth Group (UNH) Stock: What to Know Before the U.S. Market Opens on Dec. 26, 2025

Go toTop